Skip to Content

BioRegenx Inc BRGX

Morningstar Rating
$0.03 0.00 (11.17%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BRGX is trading at a 881% premium.
Price
$0.03
Fair Value
$8.54
Uncertainty
Extreme
1-Star Price
$9.50
5-Star Price
$3.56
Economic Moat
Wtkl
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BRGX is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.03
Day Range
$0.030.03
52-Week Range
$0.010.09
Bid/Ask
$0.01 / $0.41
Market Cap
$29.65 Mil
Volume/Avg
8,945 / 75,532

Key Statistics

Price/Earnings (Normalized)
Price/Sales
13.50
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

BioRegenx Inc is redefining health intelligence with new patented technologies and artificial intelligence. Its specialize in developing intellectual property (IP) and are engaged in regenerative biotherapeutics, anti-aging, artificial intelligence (AI) for healthcare and bioinformatics for public and private transportation. The primary focus involves acquiring or developing non-invasive medical and wellness devices capable of efficiently recording, storing, and analyzing extensive datasets.
Sector
Healthcare
Industry
Health Information Services
Stock Style Box
Small Core
Total Number of Employees
10

Valuation

Metric
BRGX
Price/Earnings (Normalized)
Price/Book Value
1.74
Price/Sales
13.50
Price/Cash Flow
Price/Earnings
BRGX

Financial Strength

Metric
BRGX
Quick Ratio
0.06
Current Ratio
0.28
Interest Coverage
−8.66
Quick Ratio
BRGX

Profitability

Metric
BRGX
Return on Assets (Normalized)
−17.54%
Return on Equity (Normalized)
−22.42%
Return on Invested Capital (Normalized)
−17.08%
Return on Assets
BRGX
See how this stock stacks up to its competitors with Morningstar Investor

Health Information Services Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
GE HealthCare Technologies Inc Common Stock
GEHC
Pbtpfx$36.1 Bil
Veeva Systems Inc Class A
VEEV
MjqnlshrHlbp$29.9 Bil
Pro Medicus Ltd
PMCUF
Hfcqxv$9.8 Bil
Solventum Corp
SOLV
Nwplll$9.0 Bil
HealthEquity Inc
HQY
Rtwnxdc$7.3 Bil
M3 Inc
MTHRF
Qlwyhl$6.4 Bil
M3 Inc ADR
MTHRY
Kxmdmyz$6.4 Bil
R1 RCM Inc
RCM
Pkpt$5.3 Bil
Doximity Inc Class A
DOCS
Hslvd$5.1 Bil
Tempus AI Inc Class A common stock
TEM
Gvvg$4.7 Bil

Sponsor Center